RLMD
Relmada Therapeutics·NASDAQ
--
--(--)
--
--(--)
RLMD Filings
Filing Date
Form Description
Form Type
2025-12-16
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-12-16 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-12-16
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-12-16 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-12-16
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-12-16 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-12-16
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-12-16 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-12-16
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-12-16 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-12-16
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-12-16 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-12-16
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-12-16 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-12-15
Form 8-K - Current report
Key Events
2025-12-15 · Key Events
Form 8-K - Current report
2025-11-14
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-11-14 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-11-13
Relmada Therapeutics, Inc. (RLMD) Q3 2025 Earnings Call Transcript
Earnings Call
2025-11-13 · Earnings Call
Relmada Therapeutics, Inc. (RLMD) Q3 2025 Earnings Call Transcript
